Skip to main content

Table 7 Diagnostic performances of biomarkers markers in predicting severe acute pancreatitis in patients with admission modified Marshall score <2 ( N = 142) a

From: Circulating cytokines in predicting development of severe acute pancreatitis

Predictive marker and optimal cutoff point

AUC

Sensitivity (%)

Specificity (%)

LR+

LR-

DOR

IL-8 (>88.1 pg/ml)

0.79 (0.68 to 0.90)

25.6 (11.7 to 54.7)

95.3 (90.2 to 97.8)

6.1 (2.0 to 19.0)

0.75 (0.54 to 1.05)

8.1 (2.0 to 33.6)

HGF (>3,020.1 pg/ml)

0.83 (0.73 to 0.92)

28.6 (11.7 to 54.7)

95.3 (0.90 to 97.8)

6.1 (2.0 to 19.0)

0.75 (0.54 to 1.05)

8.1 (2.0 to 33.6)

G-CSF (>477.7 pg/ml)

0.78 (0.65 to 0.90)

35.6 (16.3 to 61.2)

96.1 (91.2 to 98.3)

9.1 (3.0 to 27.7)

0.67 (0.45 to 0.99)

13.7 (3.3 to 56.1)

CRP (>227 mg/L)

0.54 (0.37 to 0.70)

7.1 (1.3 to 31.5)

95.3 (90.2 to 97.8)

1.5 (0.2 to 11.8)

0.97 (0.2 to 11.8)

1.6 (0.2 to 14.0)

Creatinine (>141 μmol/L)

0.62 (0.45 to 0.79)

7.1 (1.3 to 31.5)

99.2 (95.7 to 99.9)

9.1 (0.6 to 37.2)

0.94 (0.91 to 1.08)

9.7 (0.57 to 164.2)

Calcium (<1.91 mmol/L)

0.74 (0.60 to 0.88)

36.4 (15.2 to 64.6)

94.3 (88.7 to 97.2)

6.4 (2.2 to 18.5)

0.68 (0.43 to 1.06)

9.5 (2.2 to 40.2)

G-CSF + IL-8 + HGF

 

57.1 (32.6 to 78.6)

90.6 (84.3 to 94.6)

6.1 (3.0 to 12.3)

0.47 (0.26 to 0.87)

12.9 (3.8 to 43.4)

  1. aIL, Interleukin; CRP, C-reactive protein; IL, interleukin; G-CSF, Granulocyte colony-stimulating factor; HGF, Hepatocyte growth factor; IL, Interleukin; AUC, Area under the curve; DOR, Diagnostic odds ratio; LR-, Negative likelihood ratio; LR+, Positive likelihood ratio. 95% confidence intervals are given in parentheses.